Tarsus Pharmaceuticals In... (TARS)
49.53
-1.96 (-3.81%)
At close: Apr 03, 2025, 3:59 PM
48.50
-2.08%
Pre-market: Apr 04, 2025, 04:45 AM EDT
13F Institute Ownership
Total Institutes of 197 in Tarsus Pharmaceuticals expanded their positions with an increase of 29 investors compared to the previous quarter. A reduction of 3.28M shares, as total invested capital grew by $794.07M with ownership percentage dropping from 113.05% to 104.51%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 4.307
4.31
Call Flow 72,700
19%
Put Flow 313,100
81%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 9.22% | 3.54M | -5.77% | 195.95M | < 0.01% |
| Rtw Investments, LP | 8.43% | 3.24M | -5.16% | 179.21M | 2.71% |
| Paradigm Biocapital Advisors L... | 6.60% | 2.53M | +3.75% | 140.19M | 4.88% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.